XML 57 R46.htm IDEA: XBRL DOCUMENT v3.8.0.1
Fair Value - Quantitative Information about Inputs and Valuation Methodologies Used for Fair Value Measurements Classification (Detail) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended 12 Months Ended
Apr. 28, 2017
Mar. 31, 2018
Dec. 31, 2017
Senhance Surgical Robotic System Acquisition [Member] | Significant Unobservable Inputs (Level 3) [Member] | Contingent Consideration [Member]      
Fair Value Inputs Liabilities Quantitative Information [Line Items]      
Probability of occurrence   100.00%  
Senhance Surgical Robotic System Acquisition [Member] | Significant Unobservable Inputs (Level 3) [Member] | Contingent Consideration [Member] | Minimum [Member]      
Fair Value Inputs Liabilities Quantitative Information [Line Items]      
Milestone dates   2018  
Discount rate   7.50%  
Senhance Surgical Robotic System Acquisition [Member] | Significant Unobservable Inputs (Level 3) [Member] | Contingent Consideration [Member] | Maximum [Member]      
Fair Value Inputs Liabilities Quantitative Information [Line Items]      
Milestone dates   2020  
Discount rate   12.00%  
Series B Warrant [Member]      
Fair Value Inputs Liabilities Quantitative Information [Line Items]      
Estimated fair value of warrants $ 6.2 $ 11.7 $ 14.1
Valuation methodology Black- Scholes Merton Monte Carlo Monte Carlo
Fair value input, term 5 years 4 years 29 days 4 years 3 months 29 days
Fair value input, risk free rate 1.81% 2.48% 2.13%
Fair value input, volatility 73.14% 85.60% 80.60%
Share price $ 0.65 $ 1.70 $ 1.93
Probability of additional financing in 2018   25.00% 25.00%
Probability of additional financing in 2019   75.00% 75.00%